Non-Current Assets
PP&E (Net)
United Therapeutics PP&E (Net) increased by 6.4% to $1.84B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 41.3%, from $1.30B to $1.84B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 18.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
An increase indicates ongoing investment in physical capacity, whereas a decline may suggest aging assets or a strategy of asset-light operations.
Detailed definition
This metric represents the book value of tangible assets after subtracting accumulated depreciation from the total histo...
Peer comparison
Standard line item for all manufacturing and industrial companies; directly comparable across peers.
Metric ID:
property_plant_equipment_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $715.70M | $726.70M | $780.90M | $784.40M | $791.40M | $840.80M | $861.50M | $896.50M | $938.90M | $992.20M | $1.05B | $1.07B | $1.09B | $1.16B | $1.22B | $1.30B | $1.36B | $1.56B | $1.73B | $1.84B |
| QoQ Change | — | +1.5% | +7.5% | +0.4% | +0.9% | +6.2% | +2.5% | +4.1% | +4.7% | +5.7% | +5.4% | +2.7% | +1.9% | +5.7% | +5.7% | +6.6% | +4.6% | +14.2% | +11.2% | +6.4% |
| YoY Change | — | — | — | — | +10.6% | +15.7% | +10.3% | +14.3% | +18.6% | +18.0% | +21.3% | +19.8% | +16.6% | +16.6% | +16.9% | +21.3% | +24.5% | +34.5% | +41.5% | +41.3% |
Range$715.70M – $1.84B
CAGR+22.0%
Avg YoY Growth+21.4%
Median YoY Growth+18.3%
Current Streak19+ quarters growth
Geographic Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Rest-of-World | $12.80M | $12.60M | $12.00M | $11.70M | $15.80M |
| Total | $780.90M | $861.50M | $1.05B | $1.22B | $1.73B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is United Therapeutics's pp&e (net)?
- United Therapeutics (UTHR) reported pp&e (net) of $1.84B in Q1 2026.
- How has United Therapeutics's pp&e (net) changed year-over-year?
- United Therapeutics's pp&e (net) increased by 41.3% year-over-year, from $1.30B to $1.84B.
- What is the long-term trend for United Therapeutics's pp&e (net)?
- Over 5 years (2020 to 2025), United Therapeutics's pp&e (net) has grown at a 18.8% compound annual growth rate (CAGR), from $731.60M to $1.73B.
- What does pp&e (net) mean?
- The current book value of physical assets after accounting for wear and tear.